Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
about
Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart DiseaseImproving Cell Engraftment in Cardiac Stem Cell TherapyHow to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesParacrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine heartsCardiovascular risks associated with low dose ionizing particle radiationInhibitory effect of hepatocyte growth factor on cardiomyocytes apoptosis is partly related to reduced calcium sensing receptor expression during a model of simulated ischemia/reperfusionGuided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarctionHypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells.Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction.Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cellsProtein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jellyToll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injurySimvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia.Excitation-contraction coupling in ventricular myocytes is enhanced by paracrine signaling from mesenchymal stem cells.Empowering adult stem cells for myocardial regenerationMesenchymal stem cells as therapeutics and vehicles for gene and drug deliveryNew vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature.Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling.Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury.Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction modelThe relative contribution of paracine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair.Mesenchymal stem cells at the intersection of cell and gene therapy.Quantification of Mesenchymal Stem Cell (MSC) delivery to a target site using in vivo confocal microscopy.Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular diseaseMultimodality molecular imaging to monitor transplanted stem cells for the treatment of ischemic heart diseaseIn vivo bioluminescence for tracking cell fate and function.Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burdenN-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction.Monocyte Chemoattractant Protein-Induced Protein 1 (MCPIP1) Enhances Angiogenic and Cardiomyogenic Potential of Murine Bone Marrow-Derived Mesenchymal Stem Cells.A long road for stem cells to cure sick hearts: update on recent clinical trials.Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells.Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue.Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models.Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps.Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough?Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells.Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model.Bone-derived mesenchymal stromal cells from HIV transgenic mice exhibit altered proliferation, differentiation capacity and paracrine functions along with impaired therapeutic potential in kidney injury.
P2860
Q26770129-0BDA0D64-ACEA-4EEA-9CBE-A991F2C76AF0Q26771255-5799FF8A-FC4F-45D8-B274-E8D25295B81CQ26774939-9F40B7D0-9E66-4860-BB68-62A9F24FE9AEQ26799107-42EA7A57-2C96-48A6-ABF2-7AA15BACFFDEQ27304850-CE1C5621-BDFD-4535-855B-E58BA078D7B5Q27335261-6C46D06F-13E1-450A-9AA0-34A97051707EQ28572745-28371043-6CA7-40D5-B3A9-D23C7468BC4EQ30496413-744E235A-475D-4F81-AD03-B21658444461Q30539770-2BA698F6-0ACF-4FED-BC0B-60B0606DE95DQ33722274-C17D4370-D709-4AAB-A08E-0CC2CB64ACD9Q33746224-01C677B9-15E2-413B-9394-4D660C97D3E7Q33746687-A98D2ED4-4234-4292-A80A-A99589044FA8Q33840741-910CC3F4-1BCD-40F0-A4FB-8879EB1778BDQ33892777-81BAFD11-D31E-446E-BFE1-82D5AF90A129Q34215785-5869BF9C-8F20-413A-8DC9-5575BBC5BB98Q34239856-271930CD-E89B-47FB-916A-415582EBEB38Q34349428-D3F72B83-233B-4700-829A-A10765163AE0Q34422460-CB82423F-3738-4E97-B6AD-A8D2F8AB2F1DQ34509669-02CE0EC6-1DC9-4D5D-9725-E76854209FD1Q34562089-D7661225-C163-4C63-B651-3AE9FCE25E3DQ34622172-CFA4ECD4-19C6-4516-BE47-6911B36B8F23Q34634535-2E76F40B-F2E7-4634-9C4F-D30A30E4AAFBQ34676808-18DE0FA3-0AD5-47C8-9818-1B426D7A9876Q35036107-99061FAF-07A4-4837-AFB4-9D7C9A5E17B6Q35086969-E5D55A1D-A7FE-4BDD-BCDE-3FF3BC365F03Q35114568-DF69A663-A246-43EB-BA94-75365CC312AAQ35314819-DF27D735-8FED-4076-8449-2633C1F4367DQ35443998-5B4473FA-65DC-42F5-A83C-1CF1045345D0Q35665230-24CA32D9-05EE-4797-A425-6775AAF45898Q35716157-C50E7F14-425B-4D9A-B46C-0E67EC4F9A0AQ35794808-DC127CF6-7378-4C0C-B5CD-DD02792178FCQ35849951-927CCBA2-855C-45EE-B8A4-401A9B6D4FCBQ36135052-3C998249-0052-43E1-A065-921FDAB702B8Q36138509-D29FEA8B-F82E-4A82-B1B2-3AC5DD261B1FQ36188460-95F0BA39-453A-4661-9F78-61DBEEB1E58FQ36657651-93E77658-AC0C-4396-B818-67ED61D3328BQ36771430-1B90618F-2DD4-4D08-AF3E-A248327850CFQ37041753-BB2C505F-E195-4B7C-A7FF-CBD0DC96B9FAQ37099897-917DB910-649E-40DE-8433-8A39EEF3001DQ37189938-F57C76F1-E98E-4ADA-8CBD-3ABDFF3ABF01
P2860
Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Hepatocyte growth factor or va ...... r acute myocardial infarction.
@en
Hepatocyte growth factor or va ...... r acute myocardial infarction.
@nl
type
label
Hepatocyte growth factor or va ...... r acute myocardial infarction.
@en
Hepatocyte growth factor or va ...... r acute myocardial infarction.
@nl
prefLabel
Hepatocyte growth factor or va ...... r acute myocardial infarction.
@en
Hepatocyte growth factor or va ...... r acute myocardial infarction.
@nl
P2093
P50
P1433
P1476
Hepatocyte growth factor or va ...... r acute myocardial infarction.
@en
P2093
Christoph Peter
Sonja Schrepfer
Thomas Eschenhagen
Tobias Deuse
William Stein
Wolfram H Zimmermann
P304
P356
10.1161/CIRCULATIONAHA.108.843680
P407
P433
P577
2009-09-01T00:00:00Z